Recent News

Jun 20, 2017

Stewardship / Resistance Scan for Jun 20, 2017

New antibiotic OK'd
MDR-TB in US kids
Virus tests and stewardship
Penalties for poor Rx
US Candida auris
Resistance testing
May 22, 2017

Stewardship / Resistance Scan for May 22, 2017

Pneumonia antibiotic failure
MDR-TB mortality
MDR Salmonella in poultry
Apr 07, 2017

Stewardship / Resistance Scan for Apr 07, 2017

KFC cuts antibiotics
MRSA incidence in the US
Potential MDR-TB drugs
Mar 27, 2017

Stewardship / Resistance Scan for Mar 27, 2017

Diagnostic test competition
MDR-TB in African migrants
Stewardship in Aruba
Mar 24, 2017
TB screening

Tuberculosis declines in US, Europe, but issues remain

TB cases among people of foreign origin pose problems for disease elimination, officials say.

Mar 23, 2017
Drug-resistant Mycobacterium tuberculosis

Report warns of rise in drug-resistant tuberculosis

About 20% of TB cases globally are resistant, and 5% are resistant to both isoniazid and rifampicin.

Mar 20, 2017

News Scan for Mar 20, 2017

Saudi MERS cases
Drug-resistant Salmonella outbreak
More chikungunya
TB/HIV in Europe
Stewardship in peds urgent care
New AMR diagnostic tool
Feb 28, 2017

Stewardship / Resistance Scan for Feb 28, 2017

Drug-resistant TB plea
MDR infections in organ transplants
Stewardship app
Feb 22, 2017

Stewardship / Resistance Scan for Feb 22, 2017

MDR Enterobacteriaceae in children
MCR-1 in Chinese pets
MDR-TB testing, treatment
Jan 20, 2017
TB bacteria

Highly drug-resistant TB spreading person to person: study

TB resistant to at least 4 antibiotics is primarily spreading person to person in South Africa.

Resources & Literature

Recent Literature

Adjemian J, Frankland TB, Daida YG, et al. Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA. Emerg Infect Dis 2017 (published online Feb 3)

Aibana O, Acharya X, Huang CC, et al. Nutritional status and tuberculosis risk in adult and pediatric household contacts. PLoS One 2016 Nov 11;11(11):e0166333

Aibana O, Bachmaha M, Krasiuk V, et al. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine. BMC Infect Dis 2017 Feb 7;17:129

Aldridge RW, Zenner D, White PJ, et al. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519,955 migrants screened before entry to England, Wales, and Northern Ireland. Lancet 2016 (published online Oct 11)

Ansumana R, Keitell S, Roberts GMT, et al. Impact of infectious disease epidemics on tuberculosis diagnostic, management and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa. Int J Infect Dis 2016 (published online Nov 3)

Arinaminpathy N, Batra D, Khaparde S, et al. The number of privately treated tuberculosis cases in India: an estimation from drug sales data. Lancet Infect Dis 2016 (published online Aug 24)

Arnold A, Cooke GS, Kon OM, et al. Drug resistant TB: UK multicentre study (DRUMS): treatment, management and outcomes in London and West Midlands 2008-2014. J Infect 2016 (published online Dec 18)

Benoit SR, Gregg EW, Jonnalagadda S, et al. Association of diabetes and tuberculosis disease among US-bound adult refugees, 2009-2014. (Letter) Emerg Infect Dis 2017 (published online Jan 26)

Boeree MJ, Heinrich N, Aarnoutse R, et al. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. Lancet Infect Dis 2016 (published online Oct 26)

Bonnett LJ, Ken-Dror G, Koh G, et al. Comparing the efficacy of drug regimens for pulmonary tuberculosis: meta-analysis of endpoints in early phase clinical trials. Clin Infect Dis 2017 (published online Apr 10)

Bourdillon PM, Goncalves CCM, Pelissari DM, et al. Increase in tuberculosis cases among prisoners, Brazil, 2009-2014. Emerg Infect Dis 2017 (published online Jan 26)

Bozorgmehr K, Razum O, Saure D, et al. Yield of active screening for tuberculosis among asylum seekers in Germany: a systematic review and meta-analysis. Euro Surveill 2017 Mar 23;22(12):pii=30491

Calligaro GL, Zikenah LS, Peter JG, et al. Effect of new tuberculosis diagnostic technologies on community-based intensified case finding: a multicenter randomized controlled trial. Lancet Infect Dis 2017 (published online Jan 4)

Cathey EF, Matthias J, Beedie KA, et al. Large tuberculosis contact investigation involving two hospitals — Okaloosa County, Florida, 2014. (Notes from the field) MMWR 2016 Dec 2;65(47):1349-50

CDC. TB guidelines. Aug 11, 2016

Chen MY, Lo YC, Chen WC, et al. Recurrence after successful treatment of multidrug-resistant tuberculosis in Taiwan. PLoS One 2017 Jan 26;12(1):e0170980

Cheng MP, Chakra CNA, Yansouni CP, et al. Risk of active tuberculosis in patients with cancer: a systematic review and meta-analysis. Clin Infect Dis 2016 (published online Dec 16)

Chiang SS, Starke JR, Miller AC, et al. Baseline predictors of treatment outcomes in children with multidrug-resistant tuberculosis: a retrospective cohort study. Clin Infect Dis 2016 (published online Jul 25)

Dale KD, Tay EL, Trauer JM, et al. Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002-2015. BMC Infect Dis 2017 May 3;17:324

de Vries G, Tsolova S, Anderson LF, et al. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries — learning from country experiences. BMC Public Health 2017 Apr 19;17:334

de Vries SG, Cremers AL, Heuvelings CC, et al. Barriers and facilitators to the uptake of tuberculosis diagnostic and treatment services by hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review of qualitative literature. Lancet Infect Dis 2017 (published online Mar 10)

Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med 2017 (published online Mar 23)

Eldholm V, Rieux A, Monteserin J, et al. Impact of HIV co-infection on the evolution and transmission of multidrug-resistant tuberculosis. eLife Sci 2016 Aug 9

Eshetie S, Bizachew M, Dagnew M, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis 2017 Mar 20;17:219

Gegla M, Winters N, Benedetti A, et al. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis 2016 (published online November 16)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation 3MGilead Become an underwriter»